These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24262762)

  • 1. Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).
    Van Tassell BW; Arena R; Biondi-Zoccai G; Canada JM; Oddi C; Abouzaki NA; Jahangiri A; Falcao RA; Kontos MC; Shah KB; Voelkel NF; Dinarello CA; Abbate A
    Am J Cardiol; 2014 Jan; 113(2):321-327. PubMed ID: 24262762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
    Van Tassell BW; Trankle CR; Canada JM; Carbone S; Buckley L; Kadariya D; Del Buono MG; Billingsley H; Wohlford G; Viscusi M; Oddi-Erdle C; Abouzaki NA; Dixon D; Biondi-Zoccai G; Arena R; Abbate A
    Circ Heart Fail; 2018 Aug; 11(8):e005036. PubMed ID: 30354558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
    Van Tassell BW; Canada J; Carbone S; Trankle C; Buckley L; Oddi Erdle C; Abouzaki NA; Dixon D; Kadariya D; Christopher S; Schatz A; Regan J; Viscusi M; Del Buono M; Melchior R; Mankad P; Lu J; Sculthorpe R; Biondi-Zoccai G; Lesnefsky E; Arena R; Abbate A
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).
    Van Tassell BW; Buckley LF; Carbone S; Trankle CR; Canada JM; Dixon DL; Abouzaki N; Oddi-Erdle C; Biondi-Zoccai G; Arena R; Abbate A
    Clin Cardiol; 2017 Sep; 40(9):626-632. PubMed ID: 28475816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) pilot study].
    Abbate A; Van Tassell BW; Biondi-Zoccai G; Kontos MC; Grizzard JD; Spillman DW; Oddi C; Roberts CS; Melchior RD; Mueller GH; Abouzaki NA; Rengel LR; Varma A; Gambill ML; Falcao RA; Voelkel NF; Dinarello CA; Vetrovec GW
    Am J Cardiol; 2013 May; 111(10):1394-400. PubMed ID: 23453459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.
    Borlaug BA; Anstrom KJ; Lewis GD; Shah SJ; Levine JA; Koepp GA; Givertz MM; Felker GM; LeWinter MM; Mann DL; Margulies KB; Smith AL; Tang WHW; Whellan DJ; Chen HH; Davila-Roman VG; McNulty S; Desvigne-Nickens P; Hernandez AF; Braunwald E; Redfield MM;
    JAMA; 2018 Nov; 320(17):1764-1773. PubMed ID: 30398602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
    Udelson JE; Lewis GD; Shah SJ; Zile MR; Redfield MM; Burnett J; Parker J; Seferovic JP; Wilson P; Mittleman RS; Profy AT; Konstam MA
    JAMA; 2020 Oct; 324(15):1522-1531. PubMed ID: 33079154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.
    Van Tassell BW; Abouzaki NA; Oddi Erdle C; Carbone S; Trankle CR; Melchior RD; Turlington JS; Thurber CJ; Christopher S; Dixon DL; Fronk DT; Thomas CS; Rose SW; Buckley LF; Dinarello CA; Biondi-Zoccai G; Abbate A
    J Cardiovasc Pharmacol; 2016 Jun; 67(6):544-51. PubMed ID: 26906034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
    Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
    Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
    Abbate A; Trankle CR; Buckley LF; Lipinski MJ; Appleton D; Kadariya D; Canada JM; Carbone S; Roberts CS; Abouzaki N; Melchior R; Christopher S; Turlington J; Mueller G; Garnett J; Thomas C; Markley R; Wohlford GF; Puckett L; Medina de Chazal H; Chiabrando JG; Bressi E; Del Buono MG; Schatz A; Vo C; Dixon DL; Biondi-Zoccai GG; Kontos MC; Van Tassell BW
    J Am Heart Assoc; 2020 Mar; 9(5):e014941. PubMed ID: 32122219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    Kosmala W; Rojek A; Przewlocka-Kosmala M; Wright L; Mysiak A; Marwick TH
    J Am Coll Cardiol; 2016 Oct; 68(17):1823-1834. PubMed ID: 27765184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.
    Kitzman DW; Hundley WG; Brubaker PH; Morgan TM; Moore JB; Stewart KP; Little WC
    Circ Heart Fail; 2010 Jul; 3(4):477-85. PubMed ID: 20516425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.
    Van Tassell BW; Lipinski MJ; Appleton D; Roberts CS; Kontos MC; Abouzaki N; Melchior R; Mueller G; Garnett J; Canada J; Carbone S; Buckley LF; Wohlford G; Kadariya D; Trankle CR; Oddi Erdle C; Sculthorpe R; Puckett L; DeWilde C; Shah K; Angiolillo DJ; Vetrovec G; Biondi-Zoccai G; Arena R; Abbate A
    Clin Cardiol; 2018 Aug; 41(8):1004-1008. PubMed ID: 30033595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.
    Van Tassell B; Mihalick V; Thomas G; Marawan A; Talasaz AH; Lu J; Kang L; Ladd A; Damonte JI; Dixon DL; Markley R; Turlington J; Federmann E; Del Buono MG; Biondi-Zoccai G; Canada JM; Arena R; Abbate A
    J Transl Med; 2022 Jun; 20(1):270. PubMed ID: 35706006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
    Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
    JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
    Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
    J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
    Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B
    Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.
    Borlaug BA; Koepp KE; Melenovsky V
    J Am Coll Cardiol; 2015 Oct; 66(15):1672-82. PubMed ID: 26449137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Neladenoson Bialanate on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
    Shah SJ; Voors AA; McMurray JJV; Kitzman DW; Viethen T; Bomfim Wirtz A; Huang E; Pap AF; Solomon SD
    JAMA; 2019 Jun; 321(21):2101-2112. PubMed ID: 31162568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.